1. Home
  2. HZO vs REPL Comparison

HZO vs REPL Comparison

Compare HZO & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

HOLD

Current Price

$23.61

Market Cap

604.0M

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$10.21

Market Cap

721.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HZO
REPL
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
604.0M
721.7M
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
HZO
REPL
Price
$23.61
$10.21
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$34.00
$12.00
AVG Volume (30 Days)
378.2K
2.1M
Earning Date
01-22-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,309,288,000.00
N/A
Revenue This Year
$4.01
N/A
Revenue Next Year
$4.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.85
$2.68
52 Week High
$33.45
$14.80

Technical Indicators

Market Signals
Indicator
HZO
REPL
Relative Strength Index (RSI) 47.79 69.07
Support Level $22.49 $9.35
Resistance Level $25.43 $11.26
Average True Range (ATR) 1.27 0.62
MACD 0.15 0.01
Stochastic Oscillator 49.38 65.04

Price Performance

Historical Comparison
HZO
REPL

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: